As the U.K. looks to boost the economy after a major COVID hit—and the looming spotlight of Brexit—the government is creating a new £1 billion public-private partnership in life sciences.
British Patient Capital, the commercial arm of the U.K. government’s British Business Bank, is kickstarting the program, funneling £200 million to “specialist funds” designed to “unlock the potential of innovative U.K. life sciences companies so that they can grow their operations and create high-skilled jobs in the U.K.,” according to the government.
Image: Current Prime Minister Boris Johnson, when Mayor of London last decade, created new life sciences hubs and investment plans. (UK Pool via AP via Newscred)
{iframe}https://www.fiercebiotech.com/biotech/britain-bets-biotech-as-billions-set-to-pour-for-life-sciences-boost{/iframe}